SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹30 Cr | ₹20 Cr | ₹20 Cr | ₹1,655,282 Cr | ₹17 Cr |
What is the latest Operating Profit of SYNCOM FORMULATIONS (INDIA) ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹1,655,282 Cr |
| Mar2017 | ₹17 Cr |
How is Operating Profit of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 48.98 | |
| Mar2024 | ₹20 Cr | -0.67 | |
| Mar2023 | ₹20 Cr | -100.00 | |
| Mar2022 | ₹1,655,282 Cr | 9,930,201.10 | |
| Mar2017 | ₹17 Cr | - | |
Compare Operating Profit of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,263.4 Cr | 2.1% | -4.1% | -29.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.1% |
-4.1% |
-29.8% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses